Nancy Lin's guest appearances

Nancy Lin

Inside Out Health

Our MBC Life

OBR Peer-Spectives

Sara Hurvitz

Axel Grothey

Scott Kopetz

Zev Wainberg

Tanios Bekaii-Saab

Jeffrey Meyerhardt

Emily Garnett

Frederick Locke

Melissa Johnson

Maimah Karmo

Wasserman Shultz

Arjun Balar

Larry Norton

Michael Wang

Barbara Burtness

OwlTail

Brain metastases are unfortunately an all too  common and devastating complication of breast cancer.  The blood-brain barrier has long been a key obstacle to developing effective systemic therapies; however, newer agents are showing signs of overcoming this  challenge. Dr. Nancy Lin explains in this Road to a Cure episode, hosted by Victoria Goldberg.Thanks for listening!More info is available on our website:www.ourmbclife.orgGot something to share? Feedback? Email:ourmbclife@sharecancersupport.orgSend us a voice recording via email or through speakpipe on our website. Follow us on Facebook, Instagram, and Twitter @ourmbclife.

Brain metastases are unfortunately an all too  common and devastating complication of breast cancer.  The blood-brain barrier has long been a key obstacle to developing effective systemic therapies; however, newer agents are showing signs of overcoming this  challenge. Dr. Nancy Lin explains in this Road to a Cure episode, hosted by Victoria Goldberg.Thanks for listening!More info is available on our website:<a href="http://www.ourmbclife.org/" rel="nofollow" target="_blank">www.ourmbclife.org</a>Got something to share? Feedback? Email:<a href="mailto:ourmbclife@sharecancersupport.org">ourmbclife@sharecancersupport.org</a>Send us a voice recording via email or through speakpipe on our website. Follow us on Facebook, Instagram, and Twitter @ourmbclife.

S04 E12 - Dr. Nancy Lin: Are CNS Mets Becoming More Treatable? What’s New with STOP-HER2?

Dr. Nancy Lin, the Director of the Metastatic Breast Cancer Program at Dana-Farber Cancer Institute, joins Lisa Laudico and co-host, Chawnte Randall, for a conversation on the issues with brain mets research for MBC patients, some of the latest research and trials for brain mets and MBC, Dr. Lin's reflections on tele-health and how Covid 19 has impacted her.  Join the conversation and you can find links to the research discussed here in our episode notes found on our website, www.ourmbclife.org. You can also find us @ourmbclife on Facebook, Twitter, and Instagram. 

Dr. Nancy Lin, the Director of the Metastatic Breast Cancer Program at Dana-Farber Cancer Institute, joins Lisa Laudico and co-host, Chawnte Randall, for a conversation on the issues with brain mets research for MBC patients, some of the latest research and trials for brain mets and MBC, Dr. Lin's reflections on tele-health and how Covid 19 has impacted her.  Join the conversation and you can find links to the research discussed here in our episode notes found on our website, <a href="http://www.ourmbclife.org/" rel="nofollow" target="_blank">www.ourmbclife.org</a>. You can also find us @ourmbclife on Facebook, Twitter, and Instagram.

S01 E06: Conversation with Dr. Nancy Lin

Robert Figlin

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Nancy Lin, MD, Associate Professor of Medicine, Harvard Medical School Associate Chief, Division of Breast Oncology Dana-Farber Cancer Institute, discuss novel agents and recent clinical developments in breast cancer

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Nancy Lin, MD, Associate Professor of Medicine, Harvard Medical School Associate Chief, Division of Breast Oncology Dana-Farber Cancer Institute, discuss novel agents and recent clinical developments in breast cancer

Breast Cancer – Nancy Lin, MD, and Robert Figlin, MD, discuss novel agents and recent clinical developments in breast cancer from ASCO20